Blueprint Medicines Corporation focuses on Ayvakit, BLU-808, and Elenestinib with strong potential in mast cell disorders.
Astrasentan becomes the first and only endothelin A receptor antagonist to focus on proteinuria reduction in primary ...
Zavegepant was effective in relieving acute migraine symptoms, with a safety profile similar to other oral calcitonin gene-related peptide receptor antagonists.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback